A team of researchers has taken a major step toward understanding the mechanisms involved in the formation of large clumps of tau protein, a hallmark of Alzheimer's disease and several other neurodegenerative disorders.
Their findings may help to better understand the pathological process and possibly lead to developing medications to treat such devastating brain diseases. The study was published this week in the journal Proceedings of the National Academy of Sciences.
Alzheimer's disease is characterized by the death of nerve cells in the brain, resulting in progressive memory loss and cognitive decline. More than 5 million people in the United States suffer from Alzheimer's, and this number is projected to triple by 2050, according to the Alzheimer's Association. There is no cure for this devastating disease.
In Alzheimer's disease, clumps of a tau protein begin to form inside nerve cells in the brain. Brain accumulation of these aggregates are known as "neurofibrillary tangles."
Similar tangles of tau, which spread among nerve cells, are also associated with a host of other neurodegenerative diseases, collectively known as "tauopathies." These include Pick's disease, frontotemporal dementia, progressive supranuclear palsy and chronic traumatic encephalopathy.
Recent studies have demonstrated that, like some other proteins, tau can undergo liquid-liquid phase separation, a process resulting in formation of liquid-like droplets containing highly concentrated protein. This phenomenon, similar to how oil and water separate when mixed, is believed to be important for normal functions of cells. However, under certain conditions, this separation within cells may also have pathological consequences.
The new study establishes a critical link between these two phenomena--tau liquid-liquid phase separation and tangle formation--demonstrating that the environment of liquid droplets greatly facilitates aggregation of tau into fibrillar structures similar to those found in the brain of someone with Alzheimer's disease.
The researchers also describe the mechanism by which this liquid-liquid phase separation regulates clumping when different variants of tau protein are present. In particular, the authors show that, because of the unique properties of liquid droplets, the presence of a shorter, slowly aggregating tau variant inhibits clumping of a longer, normally fast aggregating variant, slowing down the overall process of tangle formation.
This novel regulatory mechanism may play a major role in determining the clinical outcome of the disease, as the ratio of these two tau variants in brain varies substantially in different tauopathies.
For example, Alzheimer's disease is usually characterized by an equal proportion of both tau isoforms, whereas fibrillary tangles in progressive supranuclear palsy and Pick's disease consist largely of the longer and shorter variant, respectively.
"While the present results provide exciting new insights into formation of pathological clumps of tau protein," the senior author said, "our study was limited to experiments with purified proteins in the test tube. The next step is to verify these findings in cell and animal models of the disease."
https://thedaily.case.edu/new-school-of-medicine-study-identifies-novel-mechanisms-that-cause-protein-clumping-in-alzheimers-and-other-degenerative-brain-diseases/
https://www.pnas.org/content/early/2020/11/30/2012460117
Novel mechanism that cause protein clumping in brain diseases
- 1,425 views
- Added
Edited
Latest News
New origin of deep brain waves
By newseditor
Posted 17 Apr
Starving cells hijack prote…
By newseditor
Posted 17 Apr
Miniature battery-free epid…
By newseditor
Posted 17 Apr
Molecular causes of differe…
By newseditor
Posted 16 Apr
Cell's 'garbage disposal' h…
By newseditor
Posted 16 Apr
Other Top Stories
New molecular probes for opioid receptors
Read more
Human brain motor regions for the hand also connect to the entire body
Read more
How dopamine drives brain activity
Read more
Low cost and highly sensitive X-ray detector using perovskite thin…
Read more
Mysterious Majorana fermion sighted on gold!
Read more
Protocols
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Modular dual-color BiAD sen…
By newseditor
Posted 31 Mar
Publications
The immunobiology of herpes…
By newseditor
Posted 17 Apr
Circulating microbiome DNA…
By newseditor
Posted 17 Apr
Spindle oscillations in com…
By newseditor
Posted 17 Apr
Oligodendroglial macroautop…
By newseditor
Posted 17 Apr
COPII with ALG2 and ESCRTs…
By newseditor
Posted 17 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar